New
IntelliSpace Precision Medicine Powered by Dana-Farber Cancer Institute

IntelliSpace Precision Medicine Oncology Pathways

Powered by Dana-Farber Cancer Institute

Find similar products

Encompass the expertise of Dana-Farber Cancer Institute through Oncology Pathways.

Features
Evidence-based content

Evidence-based content

Encompasses the expertise of over 300 oncologists, scientists, pharmacists and a team of data scientists and informatics experts at Dana-Farber Cancer Institute.
Clinical trial matching

Clinical trial matching

Automatically recommend local and national clinical trials for patients based on a variety of factors, including cancer type, specific biomarkers, prior therapies, and comorbidity status.
Elevated user experience

Elevated user experience

Interactive navigation and advanced visualization of a decision tree based on the patient profile.
Customization and adaption

Customization and adaption

Establish an oncology pathways program based on expert-curated content and adapt it to your local care setting.
Comprehensive usage

Comprehensive usage

Enable clinical and operational enhancement through comprehensive usage and adherence analytics.

Oncology Pathways from ASCO

Technology built with Oncologists, for Oncologists. Carole Tremonti, RN MBA and Dr. Dave Jackman, PhD from Dana-Farber Cancer Institute describe the partnership with Philips in the creation of Philips IntelliSpace Precision Medicine Oncology Pathways powered by Dana-Farber Cancer Institute.
* Video credited to and provided by Dana-Farber Cancer Institute.
Watch video

Oncologists have access to provide the latest supported guidance for practicing clinicians

Below are types of cancer Pathways that Dana-Farber Cancer Institute has created:
Hematologic malignancies
Leukemia

Chronic myelogenous leukemia

Myelodysplastic syndrome

Lymphoma
Hodgkin's
Non Hodgkin's

    - Burkitt’s

    - CLL/SLL

    - Double-hit lymphomas (DLBCL)

    - Follocular

    - Mantle cell

    - Marginal zone

    - T-cell

Plasma cell dyscrasias
Amyloidosis
Multiple myeloma
POEMS syndrome
Waldenstrom’s
Solid tumor malignancies
Breast
Breast cancer
Gastrointestinal
Colorectal
Gastroesophageal
Pancreatic adenocarcinoma
Genitourinary
Bladder
Prostate
Renal cell carcinoma
Testicular
Gynecologic
Cervical
Endometrial/uterine
Ovarian
Head and neck
Squamous cell carcinoma
Melanoma
Cutaneous melanoma
Neuro-Onc
Glioblastoma
Sarcoma
GI stromal tumor
Thoracic
Non-small cell lung cancer
Small cell lung cancer

Standards-based EMR integration

IntelliSpace Precision Medicine system and your enterprise information systems are connected with Philips IntelliBridge Enterprise providing a single, standards-based point of interoperability between reducing complexity and cost in your healthcare environment.
  • Single Sign-On with patient context launching directly from EMR workflow
  • A single Philips interoperability point reducing complexity
  • Standards-based HL7 data exchange supports different systems

Philips IntelliSpace Precision Medicine Oncology Pathways powered by Dana-Farber Cancer Institute encompasses the expertise of over 300 oncologists, scientists, pharmacists and a team of data scientists and informatics experts at Dana-Farber Cancer Institute (DFCI) and includes 31 medical oncology and 27 radiation oncology pathways.

Contact information

* This field is mandatory
*
*
*
*
*
*
*
*
*
By specifying your reason for contact we will be able to provide you with a better service.
*
*